NO20090334L - DHA-estere og anvendelse derav i behandling og forebygging av kordiovaskulaer sykdom - Google Patents
DHA-estere og anvendelse derav i behandling og forebygging av kordiovaskulaer sykdomInfo
- Publication number
- NO20090334L NO20090334L NO20090334A NO20090334A NO20090334L NO 20090334 L NO20090334 L NO 20090334L NO 20090334 A NO20090334 A NO 20090334A NO 20090334 A NO20090334 A NO 20090334A NO 20090334 L NO20090334 L NO 20090334L
- Authority
- NO
- Norway
- Prior art keywords
- following formula
- cardiovascular disease
- treating
- same
- preventing cardiovascular
- Prior art date
Links
- 208000024172 Cardiovascular disease Diseases 0.000 title abstract 2
- MVQVNTPHUGQQHK-UHFFFAOYSA-N 3-pyridinemethanol Chemical compound OCC1=CC=CN=C1 MVQVNTPHUGQQHK-UHFFFAOYSA-N 0.000 abstract 1
- 206010003658 Atrial Fibrillation Diseases 0.000 abstract 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 abstract 1
- KLDXJTOLSGUMSJ-JGWLITMVSA-N Isosorbide Chemical compound O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@@H]21 KLDXJTOLSGUMSJ-JGWLITMVSA-N 0.000 abstract 1
- 229940090949 docosahexaenoic acid Drugs 0.000 abstract 1
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 abstract 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 abstract 1
- -1 docosahexaenoic acid ester Chemical class 0.000 abstract 1
- 229960000367 inositol Drugs 0.000 abstract 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 abstract 1
- 229960002479 isosorbide Drugs 0.000 abstract 1
- 229960003827 isosorbide mononitrate Drugs 0.000 abstract 1
- YWXYYJSYQOXTPL-SLPGGIOYSA-N isosorbide mononitrate Chemical compound [O-][N+](=O)O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@@H]21 YWXYYJSYQOXTPL-SLPGGIOYSA-N 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229960004738 nicotinyl alcohol Drugs 0.000 abstract 1
- 229940101267 panthenol Drugs 0.000 abstract 1
- 235000020957 pantothenol Nutrition 0.000 abstract 1
- 239000011619 pantothenol Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 abstract 1
- 235000019156 vitamin B Nutrition 0.000 abstract 1
- 239000011720 vitamin B Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
- C07C69/587—Monocarboxylic acid esters having at least two carbon-to-carbon double bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/02—Preparation of carboxylic acid esters by interreacting ester groups, i.e. transesterification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0605649A FR2902659A1 (fr) | 2006-06-23 | 2006-06-23 | Ester de dha et son utilisation dans le traitement et la prevention des maladies cardiovasculaires |
| PCT/EP2007/056277 WO2007147899A2 (en) | 2006-06-23 | 2007-06-22 | Dha esters and use thereof in treatment and prevention of cardiovascular disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20090334L true NO20090334L (no) | 2009-03-04 |
Family
ID=37686083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20090334A NO20090334L (no) | 2006-06-23 | 2009-01-21 | DHA-estere og anvendelse derav i behandling og forebygging av kordiovaskulaer sykdom |
Country Status (38)
| Country | Link |
|---|---|
| US (2) | US8034377B2 (es) |
| EP (1) | EP2034999B9 (es) |
| JP (1) | JP5053372B2 (es) |
| KR (1) | KR101380128B1 (es) |
| CN (1) | CN101472590A (es) |
| AR (1) | AR061622A1 (es) |
| AT (1) | ATE489091T1 (es) |
| AU (1) | AU2007262958B2 (es) |
| BR (1) | BRPI0713725A2 (es) |
| CA (1) | CA2655570C (es) |
| CL (1) | CL2010001123A1 (es) |
| CO (1) | CO6150156A2 (es) |
| CR (1) | CR10507A (es) |
| DE (1) | DE602007010776D1 (es) |
| DK (1) | DK2034999T3 (es) |
| EC (1) | ECSP099039A (es) |
| ES (1) | ES2355611T3 (es) |
| FR (1) | FR2902659A1 (es) |
| GE (1) | GEP20125464B (es) |
| HN (1) | HN2008001771A (es) |
| HR (1) | HRP20110086T1 (es) |
| IL (1) | IL195562A (es) |
| MA (1) | MA30584B1 (es) |
| MX (1) | MX2009000103A (es) |
| MY (1) | MY145985A (es) |
| NO (1) | NO20090334L (es) |
| NZ (1) | NZ573454A (es) |
| PL (1) | PL2034999T3 (es) |
| PT (1) | PT2034999E (es) |
| RS (1) | RS51629B (es) |
| RU (1) | RU2451672C2 (es) |
| SA (1) | SA07280345B1 (es) |
| SI (1) | SI2034999T1 (es) |
| TN (1) | TNSN08527A1 (es) |
| TW (1) | TWI389888B (es) |
| UA (1) | UA96156C2 (es) |
| WO (1) | WO2007147899A2 (es) |
| ZA (1) | ZA200900334B (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2334536B1 (es) * | 2008-04-11 | 2011-01-24 | Universidad Complutense De Madrid | Procedimiento para la obtencion selectiva de 12-hidroxi-9-cis-octadecenoato de (1,4:3,6-dianhidro-d-glucitol) utilizando lipasas inmovilizadas como catalizador. |
| FR2949063B1 (fr) * | 2009-08-11 | 2011-09-30 | Pf Medicament | Composition pharmaceutique comprenant un ester de dha destinee a etre administree par voie parenterale |
| EP2582391B1 (en) | 2010-06-18 | 2018-10-03 | XBiotech, Inc | Arthritis treatment |
| FR2963790B1 (fr) | 2010-08-11 | 2012-09-28 | Pf Medicament | Docosahexaeneoate de panthenyle et son utilisation dans le traitement et la prevention des maladies cardiovasculaires |
| KR20210128021A (ko) | 2010-08-23 | 2021-10-25 | 얀센 바이오테크 인코포레이티드 | 종양성 질병들에 대한 치료 |
| US9724409B2 (en) | 2011-04-01 | 2017-08-08 | Xbiotech, Inc. | Treatment of inflammatory skin disease |
| CN102757444B (zh) * | 2011-04-29 | 2016-02-10 | 南京信诺泰医药有限公司 | 具有一氧化氮供体性质的苯并呋喃类化合物 |
| FR2998479B1 (fr) * | 2012-11-27 | 2017-04-28 | Pf Medicament | Utilisation d'un ester de dha pour le traitement prophylactique et/ou curatif de la drepanocytose |
| WO2016024283A1 (en) * | 2014-08-12 | 2016-02-18 | Praj Industries Limited | Process for the preparation of triglycerides of epa and dha |
| US10441087B2 (en) | 2015-02-24 | 2019-10-15 | Sleep Number Corporation | Mattress with adjustable firmness |
| AU2018220862A1 (en) | 2017-02-16 | 2019-08-29 | Janssen Biotech, Inc. | Treatment of hidradenitis suppurativa |
| JP2020508308A (ja) * | 2017-02-20 | 2020-03-19 | ボード オブ スーパーバイザーズ オブ ルイジアナ ステート ユニバーシティ アンド アグリカルチュアル アンド メカニカル カレッジ | 心房細動の治療及び予防における硫化水素及び／又は亜硝酸塩 |
| CN110950881A (zh) * | 2018-09-27 | 2020-04-03 | 中国科学院上海药物研究所 | 一类三环类似物、其制备方法和用途 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL133049C (es) | 1966-02-24 | |||
| JPS5967263A (ja) | 1982-10-07 | 1984-04-16 | Terumo Corp | ペンタエン高級脂肪酸ピリジルアルコ−ルエステルおよびその製法 |
| JPS5967264A (ja) | 1982-10-08 | 1984-04-16 | Terumo Corp | 血小板凝集抑制剤 |
| EP0125252A1 (de) * | 1982-11-16 | 1984-11-21 | MOTSCHAN, Georges | Neue verwendung eines einzelnen vitamins oder einer kombination verschiedener vitamine |
| JPS6034947A (ja) * | 1983-08-05 | 1985-02-22 | Terumo Corp | ドコサヘキサエン酸誘導体およびそれを用いた血小板凝集阻止剤 |
| GB9300125D0 (en) * | 1993-01-06 | 1993-03-03 | Scotia Holdings Plc | Compositions containing esters of unsaturated fatty acids |
| US5760081A (en) * | 1994-05-10 | 1998-06-02 | The General Hospital Corporation | Omega 3 fatty acids in the prevention of ventricular fibrillation |
| ES2225879T3 (es) | 1995-05-01 | 2005-03-16 | Scarista Limited | Esteres de acido nicotinico y composiciones farmaceuticas que los contienen. |
| IL118092A0 (en) | 1995-05-03 | 1996-09-12 | Smithkline Beecham Plc | Antibacterial compounds their preparation and pharmaceutical compositions containing them |
| US5919815A (en) * | 1996-05-22 | 1999-07-06 | Neuromedica, Inc. | Taxane compounds and compositions |
| US5795909A (en) | 1996-05-22 | 1998-08-18 | Neuromedica, Inc. | DHA-pharmaceutical agent conjugates of taxanes |
| AUPQ480399A0 (en) | 1999-12-22 | 2000-02-03 | Commonwealth Scientific And Industrial Research Organisation | Unsaturated fatty acids and their uses in therapy |
| EP1157692B1 (en) | 2000-05-22 | 2005-10-05 | Pro Aparts - Investimentos E Consultoria Lda | Composition of fatty acids containing at least 80% by weight of EPA and DHA or their derivatives and its pharmaceutical use |
| ITMI20010129A1 (it) * | 2001-01-25 | 2002-07-25 | Pharmacia & Upjohn Spa | Acidi grassi essenziali nella terapia di insufficienza cardiaca e scompenso cardiaco |
| US7704542B2 (en) * | 2001-09-12 | 2010-04-27 | Xanodyne Pharmaceuticals, Inc. | Vitamin/mineral compositions with DHA |
| US8729124B2 (en) * | 2002-03-05 | 2014-05-20 | Pronova Biopharma Norge As | Use of EPA and DHA in secondary prevention |
| ITMI20022511A1 (it) * | 2002-11-26 | 2004-05-27 | Victorix Assets Ltd | Uso di composizioni farmaceutiche contenenti esteri etilici di acidi poliinsaturi omega-3 nella orevenzione della fibrillazione atriale. |
| EP1466597A1 (en) * | 2003-04-07 | 2004-10-13 | Clinigenetics | Use of dha esters to control or prevent cardiovascular diseases |
| WO2004091603A1 (fr) * | 2003-04-07 | 2004-10-28 | Clinigenetics | Utilisation d’un ester de dha pour le traitement des malades cardiovasculaires |
| AU2004229165A1 (en) | 2003-04-17 | 2004-10-28 | Pharmaton S.A. | Multi-vitamin and mineral supplement for pregnant women |
-
2006
- 2006-06-23 FR FR0605649A patent/FR2902659A1/fr active Pending
-
2007
- 2007-06-22 BR BRPI0713725-7A patent/BRPI0713725A2/pt not_active IP Right Cessation
- 2007-06-22 WO PCT/EP2007/056277 patent/WO2007147899A2/en active Application Filing
- 2007-06-22 GE GEAP200711074A patent/GEP20125464B/en unknown
- 2007-06-22 AT AT07765584T patent/ATE489091T1/de active
- 2007-06-22 PT PT07765584T patent/PT2034999E/pt unknown
- 2007-06-22 JP JP2009517144A patent/JP5053372B2/ja not_active Expired - Fee Related
- 2007-06-22 EP EP07765584A patent/EP2034999B9/en active Active
- 2007-06-22 KR KR1020097001053A patent/KR101380128B1/ko not_active Expired - Fee Related
- 2007-06-22 DK DK07765584.3T patent/DK2034999T3/da active
- 2007-06-22 CA CA2655570A patent/CA2655570C/en not_active Expired - Fee Related
- 2007-06-22 RU RU2008152248/04A patent/RU2451672C2/ru not_active IP Right Cessation
- 2007-06-22 AR ARP070102779A patent/AR061622A1/es not_active Application Discontinuation
- 2007-06-22 DE DE602007010776T patent/DE602007010776D1/de active Active
- 2007-06-22 MX MX2009000103A patent/MX2009000103A/es active IP Right Grant
- 2007-06-22 PL PL07765584T patent/PL2034999T3/pl unknown
- 2007-06-22 MY MYPI20084785A patent/MY145985A/en unknown
- 2007-06-22 TW TW096122472A patent/TWI389888B/zh not_active IP Right Cessation
- 2007-06-22 SI SI200730469T patent/SI2034999T1/sl unknown
- 2007-06-22 RS RS20110091A patent/RS51629B/en unknown
- 2007-06-22 UA UAA200900468A patent/UA96156C2/ru unknown
- 2007-06-22 NZ NZ573454A patent/NZ573454A/en not_active IP Right Cessation
- 2007-06-22 AU AU2007262958A patent/AU2007262958B2/en not_active Ceased
- 2007-06-22 US US12/305,162 patent/US8034377B2/en not_active Expired - Fee Related
- 2007-06-22 CN CNA2007800228209A patent/CN101472590A/zh active Pending
- 2007-06-22 ES ES07765584T patent/ES2355611T3/es active Active
- 2007-06-23 SA SA07280345A patent/SA07280345B1/ar unknown
-
2008
- 2008-11-27 IL IL195562A patent/IL195562A/en active IP Right Grant
- 2008-11-27 HN HN2008001771A patent/HN2008001771A/es unknown
- 2008-12-12 CR CR10507A patent/CR10507A/es unknown
- 2008-12-19 TN TNP2008000527A patent/TNSN08527A1/en unknown
-
2009
- 2009-01-07 EC EC2009009039A patent/ECSP099039A/es unknown
- 2009-01-09 MA MA31561A patent/MA30584B1/fr unknown
- 2009-01-15 ZA ZA2009/00334A patent/ZA200900334B/en unknown
- 2009-01-21 NO NO20090334A patent/NO20090334L/no not_active Application Discontinuation
- 2009-01-22 CO CO09005510A patent/CO6150156A2/es unknown
-
2010
- 2010-10-13 CL CL2010001123A patent/CL2010001123A1/es unknown
-
2011
- 2011-02-03 HR HR20110086T patent/HRP20110086T1/hr unknown
- 2011-06-13 US US13/159,022 patent/US8227479B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20090334L (no) | DHA-estere og anvendelse derav i behandling og forebygging av kordiovaskulaer sykdom | |
| CY1122629T1 (el) | Αιθυλεστερας εικοσαπενταενοϊκου οξεος για θεραπεια υπερτριγλυκεριδαιμιας | |
| CY1123945T1 (el) | Στοματικα σκευασματα αμεσης απελευθερωσης για υποκατεστημενες κιναζολινονες | |
| MX378496B (es) | Metodos para reducir riesgo de evento cardiovascular en sujeto con terapia con estatina. | |
| WO2009091538A8 (en) | Pharmaceutical composition comprising epa and dha for treating hypertriglyceridemia and hypercholesterolemia | |
| BR112012006692B8 (pt) | composição farmacêutica compreendendo um derivado de hidróxi de atorvastatina e um óleo compreendendo etil eicosapentaenoato ou etil docosahexaenoato | |
| NZ734905A (en) | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same | |
| AR075423A1 (es) | Composicion farmaceutica que comprende un inhibidor de sglt-2, forma farmaceutica, procedimiento para su preparacion, metodos de tratamiento y sus usos | |
| NZ618734A (en) | Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas | |
| AU2016219643A1 (en) | Pharmaceutical combination for the treatment of pain | |
| NO20074318L (no) | Anvendelse av en fettsyresammensetning som inneholder DHA for fremstilling av et medisinsk produkt eller et naeringsmiddel for behandling av amyloidoserelaterte sykdommer | |
| MA31094B1 (fr) | Utilisation de dérivés de pyranone-acide substituée pour le traitement du syndrome métabolique | |
| WO2009099553A3 (en) | Use of kinase inhibitor in treatment of atherosclerosis | |
| WO2009097228A3 (en) | Composition and method for treating and preventing musculoskeletal and connective tissue disorders | |
| NO20084478L (no) | Konjugerte lipidderivater | |
| NO20092763L (no) | Isosorbid mononitrat derivater for behandling av tarmlidelser | |
| NO20083307L (no) | Anvendelse av et ikke-forsapbart ekstrakt fra plantemasse ved behandling av hudaldring | |
| WO2010047559A2 (ko) | 방출성이 제어된 약제학적 제제 | |
| NO20076426L (no) | Aktiv sammensetning for behandling eller for a unnga problemer relatert til forstyrrelse av den biologiske klokken | |
| WO2009015447A3 (en) | Polyacetal-carboxylic acids in the treatment of cancer and auto-immune disorders | |
| TH82586A (th) | สารประกอบควิโนลิน | |
| TH142638A (th) | สูตรผสมเชิงซ้อนที่ประกอบรวมด้วย เลอร์คานิดิปีน ไฮโดรคลอไรด์ และ วาลซาร์แทนและวิธีการสำหรับการเตรียมของสูตรผสมเชิงซ้อนนี้ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |